68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer
NCT02282137
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
208
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
68Ga-PSMA
Sponsor
Ebrahim Delpassand
Collaborators
[object Object]
[object Object]